insights_auto
Outlook: 73.3% bullish·0.0% bearish
Go to analysischevron_right
COLG34:BVMF
Colgate BDR
R$76.01
arrow_downward
-1.94%(-1.50) 1D
Nov 6, 12:04:07 PM GMT-3 · BRL
search
All symbols
No data
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for COLG34...
Open
R$77.00
High
R$77.00
Low
R$75.36
Mkt. cap
77.12B
Avg. vol.
1.13K
Volume
404.00
52-wk high
R$77.84
52-wk low
R$57.22
Shares outstanding
794.92M
No. of employees
34K
Open
R$77.00
High
R$77.00
Low
R$75.36
Mkt. cap
77.12B
Avg. vol.
1.13K
Volume
404.00
52-wk high
R$77.84
52-wk low
R$57.22
Shares outstanding
794.92M
No. of employees
34K
News stories
From web sources and news partners
Investing.com Nigeria
·
10 hours ago
Form 144 COLGATE PALMOLIVE CO For: 6 November By Investing.com
www.debelegger.nl
·
13 hours ago
Colgate-Palmolive (CL) Stock Price, Chart & Analysis
Yahoo Finance
·
21 hours ago
Procter & Gamble vs. Colgate-Palmolive: Which Dividend Stock Is Safer?
Barchart.com
·
1 day ago
Colgate-Palmolive Stock Outlook: Is Wall Street Bullish or Bearish?
Profile
The Colgate-Palmolive Company, commonly known as Colgate-Palmolive, is an American multinational consumer products company headquartered on Park Avenue in Midtown Manhattan, New York City. The company specializes in the production, distribution, and provision of household, health care, personal care, and veterinary products. Wikipedia
About Colgate BDR
CEONoel R. Wallace
Employees33.6K
Founded1806
HeadquartersNew York, New York, United States
SectorConsumer Staples
IndustryHousehold goods
Websitecolgatepalmolive.com
Last report
Oct 30, 2026
Fiscal period
Q3 2026
- Normalized EPS / Est. (USD)
- GAAP EPS / Est. (USD)
$0.97 / $0.93
+4.83%beat
arrow_upward
Revenue / Est. (USD)
5.37B / 5.33B
+0.65%beat
arrow_upward
Fiscal Q3 2026 earnings call
youtube_liveWaiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
- Quarterly
- Annual
All values in USD | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|
Revenue | 5.23B | 5.32B | 5.36B | 5.37B |
Cost of goods sold | 2.08B | 2.10B | 2.06B | 2.13B |
Cost of revenue | 2.08B | 2.10B | 2.06B | 2.13B |
Research and development expenses | - | - | - | - |
Total research and development expenses | - | - | - | - |
Selling, general, and admin expenses | 2.00B | 2.09B | 2.14B | 2.12B |
Operating expense | 2.08B | 2.11B | 2.17B | 2.14B |
Total operating expenses | 4.16B | 4.21B | 4.24B | 4.28B |
Operating income | 1.07B | 1.11B | 1.12B | 1.09B |
Other non operating income | - | - | - | - |
EBT including unusual items | 108.00M | 892.00M | 950.00M | 1.02B |
EBT excluding unusual items | 1.04B | 1.07B | 1.08B | 1.05B |
Income tax expense | 113.00M | 211.00M | 231.00M | 240.00M |
Effective tax rate | 104.63% | 23.65% | 24.32% | 23.55% |
Other operating expenses | 77.00M | 21.00M | 30.00M | 19.00M |
Net income | -37.00M | 646.00M | 693.00M | 751.00M |
Net profit margin | -0.71% | 12.13% | 12.93% | 13.99% |
Earnings per share | 0.95 | 0.97 | 0.99 | 0.97 |
Interest and investment income | 19.00M | 16.00M | 17.00M | 17.00M |
Interest expense | -64.00M | -62.00M | -62.00M | -62.00M |
Net interest expenses | -45.00M | -46.00M | -45.00M | -45.00M |
Depreciation and amortization charges | - | - | - | - |
EBITDA | 1.24B | 1.27B | 1.28B | 1.25B |
Gain or loss from assets sale | - | - | - | - |
Upcoming events